Macrophage Migration Inhibitory Factor Induces Macrophage Recruitment via CC Chemokine Ligand 2
Julia L. Gregory(Monash Institute of Medical Research), Michael J. Hickey(Australian Regenerative Medicine Institute), Pamela Hall(Monash University), Yuan Yang(Xihua University), Sonja J. McKeown(Monash University), Shaun R. McColl(The University of Adelaide), Jennifer A. Ralph(Monash University), Eric F. Morand(Novartis (Switzerland))
Cited by 227
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726